TWI825243B - 新穎之經取代黃嘌呤衍生物 - Google Patents
新穎之經取代黃嘌呤衍生物 Download PDFInfo
- Publication number
- TWI825243B TWI825243B TW108145593A TW108145593A TWI825243B TW I825243 B TWI825243 B TW I825243B TW 108145593 A TW108145593 A TW 108145593A TW 108145593 A TW108145593 A TW 108145593A TW I825243 B TWI825243 B TW I825243B
- Authority
- TW
- Taiwan
- Prior art keywords
- mmol
- mixture
- added
- disorder
- esi
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18212060.0 | 2018-12-12 | ||
| EP18212060 | 2018-12-12 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TW202039495A TW202039495A (zh) | 2020-11-01 |
| TWI825243B true TWI825243B (zh) | 2023-12-11 |
Family
ID=64665184
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW108145593A TWI825243B (zh) | 2018-12-12 | 2019-12-12 | 新穎之經取代黃嘌呤衍生物 |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US11198696B2 (https=) |
| EP (1) | EP3894410B1 (https=) |
| JP (1) | JP7502299B2 (https=) |
| KR (1) | KR102877857B1 (https=) |
| CN (1) | CN113166151B (https=) |
| AU (1) | AU2019396499B2 (https=) |
| BR (1) | BR112021008316A2 (https=) |
| CL (1) | CL2021001509A1 (https=) |
| DK (1) | DK3894410T3 (https=) |
| EA (1) | EA202191588A1 (https=) |
| ES (1) | ES2964630T3 (https=) |
| HU (1) | HUE064908T2 (https=) |
| IL (1) | IL283768B2 (https=) |
| MX (1) | MX2021007019A (https=) |
| PH (1) | PH12021551345A1 (https=) |
| PL (1) | PL3894410T3 (https=) |
| TW (1) | TWI825243B (https=) |
| WO (1) | WO2020120450A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12064917B2 (en) | 2012-11-21 | 2024-08-20 | Stratasys, Inc. | Method for printing three-dimensional parts with cyrstallization kinetics control |
| HUE064908T2 (hu) * | 2018-12-12 | 2024-04-28 | Boehringer Ingelheim Int | Szubsztituált xantinszármazékok |
| WO2024164818A1 (zh) * | 2023-02-08 | 2024-08-15 | 中国科学院上海药物研究所 | 黄嘌呤类化合物及其用途 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014143799A2 (en) * | 2013-03-15 | 2014-09-18 | Hydra Biosciences, Inc. | Substituted xanthines and methods of use thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016023830A1 (en) | 2014-08-11 | 2016-02-18 | Hydra Biosciences, Inc. | Pyrido[2,3-d]pyrimidine-2,4(1h,3h)-dione derivatives |
| GB201702160D0 (en) | 2017-02-09 | 2017-03-29 | Univ Leeds Innovations Ltd | Inhibitors for use in therapy |
| DK3652176T3 (da) * | 2017-07-11 | 2022-01-17 | Boehringer Ingelheim Int | Substituerede xanthinderivater |
| HUE064908T2 (hu) * | 2018-12-12 | 2024-04-28 | Boehringer Ingelheim Int | Szubsztituált xantinszármazékok |
-
2019
- 2019-12-10 HU HUE19820718A patent/HUE064908T2/hu unknown
- 2019-12-10 DK DK19820718.5T patent/DK3894410T3/da active
- 2019-12-10 WO PCT/EP2019/084375 patent/WO2020120450A1/en not_active Ceased
- 2019-12-10 CN CN201980081737.1A patent/CN113166151B/zh active Active
- 2019-12-10 PL PL19820718.5T patent/PL3894410T3/pl unknown
- 2019-12-10 AU AU2019396499A patent/AU2019396499B2/en active Active
- 2019-12-10 KR KR1020217021875A patent/KR102877857B1/ko active Active
- 2019-12-10 EA EA202191588A patent/EA202191588A1/ru unknown
- 2019-12-10 EP EP19820718.5A patent/EP3894410B1/en active Active
- 2019-12-10 MX MX2021007019A patent/MX2021007019A/es unknown
- 2019-12-10 JP JP2021533340A patent/JP7502299B2/ja active Active
- 2019-12-10 ES ES19820718T patent/ES2964630T3/es active Active
- 2019-12-10 PH PH1/2021/551345A patent/PH12021551345A1/en unknown
- 2019-12-10 IL IL283768A patent/IL283768B2/en unknown
- 2019-12-10 BR BR112021008316-2A patent/BR112021008316A2/pt unknown
- 2019-12-11 US US16/710,887 patent/US11198696B2/en active Active
- 2019-12-12 TW TW108145593A patent/TWI825243B/zh active
-
2021
- 2021-06-09 CL CL2021001509A patent/CL2021001509A1/es unknown
- 2021-11-10 US US17/523,316 patent/US20220177479A1/en not_active Abandoned
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014143799A2 (en) * | 2013-03-15 | 2014-09-18 | Hydra Biosciences, Inc. | Substituted xanthines and methods of use thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| IL283768A (en) | 2021-07-29 |
| IL283768B2 (en) | 2024-05-01 |
| HUE064908T2 (hu) | 2024-04-28 |
| US11198696B2 (en) | 2021-12-14 |
| DK3894410T3 (da) | 2023-11-27 |
| AU2019396499B2 (en) | 2024-10-10 |
| WO2020120450A1 (en) | 2020-06-18 |
| KR102877857B1 (ko) | 2025-10-29 |
| CA3119229A1 (en) | 2020-06-18 |
| CL2021001509A1 (es) | 2021-12-17 |
| KR20210102955A (ko) | 2021-08-20 |
| BR112021008316A2 (pt) | 2021-08-03 |
| CN113166151B (zh) | 2023-12-01 |
| EP3894410A1 (en) | 2021-10-20 |
| PH12021551345A1 (en) | 2022-05-11 |
| JP2022512373A (ja) | 2022-02-03 |
| CN113166151A (zh) | 2021-07-23 |
| US20200190093A1 (en) | 2020-06-18 |
| MX2021007019A (es) | 2021-09-10 |
| ES2964630T3 (es) | 2024-04-08 |
| EA202191588A1 (ru) | 2021-10-18 |
| PL3894410T3 (pl) | 2024-03-18 |
| US20220177479A1 (en) | 2022-06-09 |
| JP7502299B2 (ja) | 2024-06-18 |
| EP3894410B1 (en) | 2023-10-11 |
| IL283768B1 (en) | 2024-01-01 |
| AU2019396499A1 (en) | 2021-05-27 |
| TW202039495A (zh) | 2020-11-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7114702B2 (ja) | 新規置換キサンチン誘導体 | |
| CA3203285A1 (en) | Heteroaryl carboxamide compound | |
| TWI825243B (zh) | 新穎之經取代黃嘌呤衍生物 | |
| EP3894409B1 (en) | Substituted xanthine derivatives | |
| CA3119229C (en) | Substituted xanthine derivatives | |
| EA043969B1 (ru) | Замещенные ксантиновые производные | |
| BR112019025611B1 (pt) | Compostos derivados de xantina substituídos e sais dos mesmos | |
| HK40025200A (en) | Substituted xanthine derivatives | |
| HK40025200B (en) | Substituted xanthine derivatives |